Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study

Body composition performed by computed tomography (CT) impacts on cancer patients’ prognoses and responses to treatment. Myosteatosis has been related to overall survival (OS) and disease-specific survival in colorectal cancer (CRC); however, the independent impact of the association of myosteatosis...

Full description

Bibliographic Details
Main Authors: Lara Pozzuto, Marina Nogueira Silveira, Maria Carolina Santos Mendes, Lígia Traldi Macedo, Felipe Osório Costa, Carlos Augusto Real Martinez, Cláudio Saddy Rodrigues Coy, Ademar Dantas da Cunha Júnior, José Barreto Campello Carvalheira
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.762444/full
_version_ 1830272976689299456
author Lara Pozzuto
Marina Nogueira Silveira
Maria Carolina Santos Mendes
Lígia Traldi Macedo
Felipe Osório Costa
Carlos Augusto Real Martinez
Cláudio Saddy Rodrigues Coy
Ademar Dantas da Cunha Júnior
Ademar Dantas da Cunha Júnior
José Barreto Campello Carvalheira
author_facet Lara Pozzuto
Marina Nogueira Silveira
Maria Carolina Santos Mendes
Lígia Traldi Macedo
Felipe Osório Costa
Carlos Augusto Real Martinez
Cláudio Saddy Rodrigues Coy
Ademar Dantas da Cunha Júnior
Ademar Dantas da Cunha Júnior
José Barreto Campello Carvalheira
author_sort Lara Pozzuto
collection DOAJ
description Body composition performed by computed tomography (CT) impacts on cancer patients’ prognoses and responses to treatment. Myosteatosis has been related to overall survival (OS) and disease-specific survival in colorectal cancer (CRC); however, the independent impact of the association of myosteatosis with prognosis in colon cancer (CC) and rectal cancer (RC) is still unclear. CT was performed at the L3 level to assess body composition features in 227 patients with CRC. Clinical parameters were collected. Overall survival (OS) was the primary outcome, and the secondary outcome was disease-free survival (DFS). Skeletal muscle attenuation and intramuscular adipose tissue area were associated with DFS (p = 0.003 and p = 0.011, respectively) and OS (p < 0.001 and p < 0.001, respectively) in CC patients but not in RC patients. Only the skeletal muscle area was associated with better prognosis related to OS in RC patients (p = 0.009). When CC and RC were analyzed separately, myosteatosis influenced survival negatively in CC patients, worsening DFS survival (hazard ratio [HR], 2.70; 95% confidence interval [CI], 1.07–6.82; p = 0.035) and OS (HR, 5.76; 95% CI, 1.31–25.40; p = 0.021). By contrast, the presence of myosteatosis did not influence DFS (HR, 1.02; 95% CI, 0.52–2.03; p = 0.944) or OS (HR, 0.76; 95% CI, 0.33–1.77; p = 0.529) in RC patients. Our study revealed the interference of myosteatosis in the therapy and survival of patients with CC but not in those with RC, strengthening the value of grouping the two types of cancer in body composition analyses.
first_indexed 2024-12-18T23:35:56Z
format Article
id doaj.art-a13324fbc0d84e45b21da93548d978df
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-18T23:35:56Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-a13324fbc0d84e45b21da93548d978df2022-12-21T20:47:32ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-11-011110.3389/fonc.2021.762444762444Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory StudyLara Pozzuto0Marina Nogueira Silveira1Maria Carolina Santos Mendes2Lígia Traldi Macedo3Felipe Osório Costa4Carlos Augusto Real Martinez5Cláudio Saddy Rodrigues Coy6Ademar Dantas da Cunha Júnior7Ademar Dantas da Cunha Júnior8José Barreto Campello Carvalheira9Division of Oncology, Department of Anesthesiology, Oncology and Radiology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, BrazilDivision of Oncology, Department of Anesthesiology, Oncology and Radiology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, BrazilDivision of Oncology, Department of Anesthesiology, Oncology and Radiology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, BrazilDivision of Oncology, Department of Anesthesiology, Oncology and Radiology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, BrazilDivision of Oncology, Department of Anesthesiology, Oncology and Radiology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, BrazilDivision of Gatrointestinal Surgery, Department of Surgery, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, BrazilDivision of Gatrointestinal Surgery, Department of Surgery, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, BrazilHematology and Oncology Clinics, Cancer Hospital of Cascavel, União Oeste de Estudos e Combate ao Câncer (UOPECCAN), Cascavel, BrazilDepartment of Internal Medicine, State University of Western Paraná (UNIOESTE), Cascavel, BrazilDivision of Oncology, Department of Anesthesiology, Oncology and Radiology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, BrazilBody composition performed by computed tomography (CT) impacts on cancer patients’ prognoses and responses to treatment. Myosteatosis has been related to overall survival (OS) and disease-specific survival in colorectal cancer (CRC); however, the independent impact of the association of myosteatosis with prognosis in colon cancer (CC) and rectal cancer (RC) is still unclear. CT was performed at the L3 level to assess body composition features in 227 patients with CRC. Clinical parameters were collected. Overall survival (OS) was the primary outcome, and the secondary outcome was disease-free survival (DFS). Skeletal muscle attenuation and intramuscular adipose tissue area were associated with DFS (p = 0.003 and p = 0.011, respectively) and OS (p < 0.001 and p < 0.001, respectively) in CC patients but not in RC patients. Only the skeletal muscle area was associated with better prognosis related to OS in RC patients (p = 0.009). When CC and RC were analyzed separately, myosteatosis influenced survival negatively in CC patients, worsening DFS survival (hazard ratio [HR], 2.70; 95% confidence interval [CI], 1.07–6.82; p = 0.035) and OS (HR, 5.76; 95% CI, 1.31–25.40; p = 0.021). By contrast, the presence of myosteatosis did not influence DFS (HR, 1.02; 95% CI, 0.52–2.03; p = 0.944) or OS (HR, 0.76; 95% CI, 0.33–1.77; p = 0.529) in RC patients. Our study revealed the interference of myosteatosis in the therapy and survival of patients with CC but not in those with RC, strengthening the value of grouping the two types of cancer in body composition analyses.https://www.frontiersin.org/articles/10.3389/fonc.2021.762444/fullskeletal muscle radiodensitycancersurvivalcomputerized tomographysarcopeniaskeletal muscle mass
spellingShingle Lara Pozzuto
Marina Nogueira Silveira
Maria Carolina Santos Mendes
Lígia Traldi Macedo
Felipe Osório Costa
Carlos Augusto Real Martinez
Cláudio Saddy Rodrigues Coy
Ademar Dantas da Cunha Júnior
Ademar Dantas da Cunha Júnior
José Barreto Campello Carvalheira
Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study
Frontiers in Oncology
skeletal muscle radiodensity
cancer
survival
computerized tomography
sarcopenia
skeletal muscle mass
title Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study
title_full Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study
title_fullStr Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study
title_full_unstemmed Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study
title_short Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study
title_sort myosteatosis differentially affects the prognosis of non metastatic colon and rectal cancer patients an exploratory study
topic skeletal muscle radiodensity
cancer
survival
computerized tomography
sarcopenia
skeletal muscle mass
url https://www.frontiersin.org/articles/10.3389/fonc.2021.762444/full
work_keys_str_mv AT larapozzuto myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy
AT marinanogueirasilveira myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy
AT mariacarolinasantosmendes myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy
AT ligiatraldimacedo myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy
AT felipeosoriocosta myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy
AT carlosaugustorealmartinez myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy
AT claudiosaddyrodriguescoy myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy
AT ademardantasdacunhajunior myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy
AT ademardantasdacunhajunior myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy
AT josebarretocampellocarvalheira myosteatosisdifferentiallyaffectstheprognosisofnonmetastaticcolonandrectalcancerpatientsanexploratorystudy